ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 6.6 | 6.7 | 6.4 |
| Other income | 0.1 | -0.2 | 0.1 |
| Total income | 6.7 | 6.5 | 6.6 |
| Profit before exceptional items & tax | -0.5 | 0.1 | -0.5 |
| Profit before tax | -0.5 | 0.1 | -0.5 |
| Net profit | -0.4 | 0.1 | -0.4 |
| Operating margin | -7.5% | 1.5% | -7.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +3.10% |
|---|
BSE results filing, NSE: LINKPH. Figures extracted from the filing.
Link Pharma Chem Ltd: key numbers
- Share price
- ₹26.00
- Market cap
- ₹11.55 Cr
- Revenue (annual)
- ₹27.43 Cr
- Net profit (annual)
- ₹0.08 Cr
- P/E (TTM)
- -47.1×Sector 35.5×
- Promoter holding
- 52.40%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Link Pharma Chem Ltd
All →Link Pharma Chem Other Announcement
Link Pharma Chem Ltd filed a periodic non-applicability notice for Reg 23(9) RPT disclosure. The company's paid-up capital and net worth fall below LODR thresholds, so no disclosure is required.
Link Pharma Chem Q2 FY27 Results: Net Loss of ₹0.2 Cr
Link Pharma Chem approved unaudited results for the quarter and half year ended 30 September 2026. Revenue was Rs.533.13 Lakh with a loss of Rs.22.31 Lakh for the quarter.
- Key figure
- Net loss ₹0.2 Cr
Link Pharma Chem Board Meeting Date
Link Pharma Chem's board meets on 3 November 2026 to approve unaudited half-year results. The trading window stays closed until results are declared.
Link Pharma Chem Other Announcement
Link Pharma Chem Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This routine disclosure provides the updated ownership structure for the company.
Link Pharma Chem Legal & Regulatory
Link Pharma Chem Ltd received a GST order reducing the total demand and penalty for FY 2021-22. The company plans to appeal the decision.
- Value
- ₹0.18 Cr
Link Pharma Chem Management Change
Link Pharma Chem Limited has announced the re-appointment of Rishikesh Thakur and Satish G Thakur as Executive Directors for a term of 36 months each.